Moderna will soon begin the first-ever human clinical trials for a messenger RNA-based HIV vaccine, utilizing the same technology as…
Frontline harm reductionists—including syringe service program (SSP) providers, peer outreach workers and hepatitis C testers—should be eligible for early COVID-19…